Controlled removal of human stratum corneum by pulsed laser to enhance percutaneous transport

• US 4,775,361 A
• Filed: 04/10/1986
• Issued: 10/04/1988
• Est. Priority Date: 04/10/1986
• Status: Expired due to Term

• Current Assignee: General Hospital Corporation
• Original Assignee: The General Hospital Corporation (Mass General Brigham, Inc.)
• Inventors: Jacques, Steven L., McAuliffe, Daniel J., Blank, Irvin H., Parrish, John A.
• Primary Examiner(s): Cohen, Lee S.
• Application Number:
  US06/851,117
• Time in Patent Office: 908 Days
• Field of Search: 604/20, 128/303.1, 128/395-398, 128/632, 128/635
• US Class Current: 604/20
• CPC Class Codes: A61B 18/20 using laser
• CPC Class Codes: A61B 18/203 applying laser energy to the outside of the body
• CPC Class Codes: A61B 2017/00761 Removing layer of skin tissue, e.g. wrinkles, scars or cancerous tissue
• CPC Class Codes: A61B 2017/00765 Decreasing the barrier function of skin tissue by radiated energy, e.g. using ultrasound, using laser for skin perforation
• CPC Class Codes: A61B 2018/00452 Skin
• CPC Class Codes: A61B 5/150022 for capillary blood or interstitial fluid
• CPC Class Codes: A61B 5/15136 by use of radiation, e.g. laser
• CPC Class Codes: A61K 41/0047 Sonopheresis, i.e. ultrasonically-enhanced transdermal delivery, electroporation of a pharmacologically active agent
• CPC Class Codes: A61M 37/0092 using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis

Abstract

A method of administering a therapeutic substance to a human patient, the method having the steps of ablating the stratum corneum of a region of the skin of the patient using pulsed laser light of wavelength, pulse length, pulse energy, pulse number, and pulse repetition rate sufficient to ablate the stratum corneum without significantly damaging the underlying epidermis, and applying the therapeutic substance to the region of ablation.

Claims

1. A method of facilitating percutaneous transport by overcoming the barrier function of the stratum corneum, said method comprising

ablating the stratum corneum of a region of the skin of said patient using pulsed laser light of wavelength, pulse length, pulse energy, pulse number, and pulse repetition rate sufficient to ablate said corneum without significantly damaging the underlying epidermis.

2. The method of claim 1 wherein said pulse repetition rate is less than 2 Hz.

3. The method of claim 1 wherein there is interposed between the skin of said patient and said pulsed laser light an aperture adapted to limit the laser light illuminating the skin of said patient to said region.

4. The method of claim 1, wherein said pulsed laser light is near infrared.

5. The method of claim 1, wherein said pulsed laser light has a pulse energy equal to or less than 170 mJ/cm² per pulse.

6. The method of claim 5, wherein said pulse energy is equal to or less than 100 mJ/cm² per pulse.

7. The method of claim 1, further comprising the step of applying a therapeutic substance to said region of ablation.

8. The method of claim 7 wherein said therapeutic substance comprises a polar compound, a peptide hormone, a non-peptide hormone, a non-hormone peptide or protein, or a gaseous anesthetic.